Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C472791 |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid results in decreased expression of KLK1 mRNA | decreases expression | 16788091
|
C006500 |
4-aminobenzamidine |
4-aminobenzamidine binds to and results in decreased activity of KLK1 protein | affects binding|decreases activity | 11151026
|
C019498 |
4-nitroaniline |
4-nitroaniline binds to and results in decreased activity of KLK1 protein | affects binding|decreases activity | 11151026
|
C019498 |
4-nitroaniline |
KLK1 protein affects the metabolism of 4-nitroaniline analog | affects metabolic processing | 2330740
|
D000535 |
Aluminum |
Aluminum binds to and results in decreased activity of KLK1 protein | affects binding|decreases activity | 15558947
|
D000584 |
Amiloride |
KLK1 protein affects the susceptibility to [Amiloride results in increased secretion of Sodium] | affects response to substance|increases secretion | 18086683
|
D000584 |
Amiloride |
KLK1 protein results in increased susceptibility to Amiloride | increases response to substance | 18086683
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of KLK1 mRNA | affects expression | 16483693
|
C023650 |
aniline |
aniline binds to and results in decreased activity of KLK1 protein | affects binding|decreases activity | 11151026
|
C032157 |
benzamidine |
benzamidine binds to and results in decreased activity of KLK1 protein | affects binding|decreases activity | 11151026
|
D002118 |
Calcium |
Calcium results in decreased activity of KLK1 protein | decreases activity | 15558947
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in increased expression of KLK1 mRNA | increases expression | 16644059
|
D002945 |
Cisplatin |
KLK1 protein affects the susceptibility to Cisplatin | affects response to substance | 16217747
|
D004280 |
Dobutamine |
KLK1 protein affects the susceptibility to Dobutamine | affects response to substance | 12411458
|
D004958 |
Estradiol |
Estradiol affects the expression of KLK1 mRNA | affects expression | 15598610
|
C025314 |
ferric citrate |
ferric citrate results in decreased activity of KLK1 protein | decreases activity | 6421970
|
C020748 |
ferrous sulfate |
ferrous sulfate results in decreased activity of KLK1 protein | decreases activity | 6421970
|
D005419 |
Flavonoids |
Flavonoids results in increased expression of KLK1 mRNA | increases expression | 18035473
|
D005632 |
Fructose |
KLK1 protein inhibits the reaction [Fructose results in increased expression of AGTR1B mRNA] | decreases reaction|increases expression | 14568997
|
D005632 |
Fructose |
KLK1 protein inhibits the reaction [Fructose results in increased expression of EDN1 mRNA] | decreases reaction|increases expression | 14568997
|
D005632 |
Fructose |
KLK1 protein inhibits the reaction [Fructose results in increased expression of EDNRA mRNA] | decreases reaction|increases expression | 14568997
|
D005839 |
Gentamicins |
icatibant inhibits the reaction [KLK1 protein inhibits the reaction [Gentamicins results in increased expression of ICAM1 protein]] | decreases reaction|increases expression | 16401625
|
D005839 |
Gentamicins |
icatibant inhibits the reaction [KLK1 protein inhibits the reaction [Gentamicins results in increased expression of TGFB1 protein]] | decreases reaction|increases expression | 16401625
|
D005839 |
Gentamicins |
icatibant inhibits the reaction [KLK1 protein inhibits the reaction [Gentamicins results in increased phosphorylation of MAPK8 protein]] | decreases reaction|increases phosphorylation | 16401625
|
D005839 |
Gentamicins |
KLK1 protein inhibits the reaction [Gentamicins results in decreased abundance of Nitric Oxide] | decreases abundance|decreases reaction | 16401625
|
D005839 |
Gentamicins |
KLK1 protein inhibits the reaction [Gentamicins results in increased expression of CCL2 protein] | decreases reaction|increases expression | 16401625
|
D005839 |
Gentamicins |
KLK1 protein inhibits the reaction [Gentamicins results in increased expression of ICAM1 protein] | decreases reaction|increases expression | 16401625
|
D005839 |
Gentamicins |
KLK1 protein inhibits the reaction [Gentamicins results in increased expression of TGFB1 protein] | decreases reaction|increases expression | 16401625
|
D005839 |
Gentamicins |
KLK1 protein inhibits the reaction [Gentamicins results in increased phosphorylation of MAPK8 protein] | decreases reaction|increases phosphorylation | 16401625
|
D005839 |
Gentamicins |
KLK1 protein results in decreased susceptibility to Gentamicins | decreases response to substance | 16401625
|
C065679 |
icatibant |
icatibant inhibits the reaction [KLK1 protein inhibits the reaction [Gentamicins results in increased expression of ICAM1 protein]] | decreases reaction|increases expression | 16401625
|
C065679 |
icatibant |
icatibant inhibits the reaction [KLK1 protein inhibits the reaction [Gentamicins results in increased expression of TGFB1 protein]] | decreases reaction|increases expression | 16401625
|
C065679 |
icatibant |
icatibant inhibits the reaction [KLK1 protein inhibits the reaction [Gentamicins results in increased phosphorylation of MAPK8 protein]] | decreases reaction|increases phosphorylation | 16401625
|
C065679 |
icatibant |
icatibant inhibits the reaction [KLK1 protein results in increased abundance of Nitric Oxide] | decreases reaction|increases abundance | 16401625
|
D008274 |
Magnesium |
Magnesium results in decreased activity of KLK1 protein | decreases activity | 15558947
|
D008770 |
Methylnitrosourea |
Methylnitrosourea results in increased expression of KLK1 mRNA | increases expression | 15240709
|
D009569 |
Nitric Oxide |
icatibant inhibits the reaction [KLK1 protein results in increased abundance of Nitric Oxide] | decreases reaction|increases abundance | 16401625
|
D009569 |
Nitric Oxide |
KLK1 protein inhibits the reaction [Gentamicins results in decreased abundance of Nitric Oxide] | decreases abundance|decreases reaction | 16401625
|
D009569 |
Nitric Oxide |
KLK1 protein results in increased abundance of Nitric Oxide | increases abundance | 16401625
|
D011188 |
Potassium |
Potassium results in decreased activity of KLK1 protein | decreases activity | 15558947
|
D012964 |
Sodium |
Sodium results in decreased activity of KLK1 protein | decreases activity | 15558947
|
D012964 |
Sodium |
KLK1 protein affects the susceptibility to [Amiloride results in increased secretion of Sodium] | affects response to substance|increases secretion | 18086683
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of KLK1 mRNA | increases expression | 16267337
|
D014212 |
Tretinoin |
Tretinoin results in decreased expression of KLK1 mRNA | decreases expression | 16788091
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.64 | 11752688 15322242 14514962 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.35 | 18287403 |
MESH:D058186 |
Acute Kidney Injury |
|
Cisplatin |
8.51 | 15814532 12690470 17670903 |
MESH:D058186 |
Acute Kidney Injury |
|
Gentamicins |
8.51 | 11274264 |
MESH:D000230 |
Adenocarcinoma |
|
Cisplatin |
6.96 | 11798837 17638652 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
6.96 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Methylnitrosourea |
6.96 | 15113128 15688392 |
MESH:D000236 |
Adenoma |
|
Magnesium |
4.43 | 17823441 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.17 | 16835633 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.45 | 15955085 |
MESH:D000544 |
Alzheimer Disease |
|
Aluminum |
4.96 | 10721010 17662457 |
MESH:D000544 |
Alzheimer Disease |
|
Nitric Oxide |
4.96 | 17556102 |
MESH:D000740 |
Anemia |
|
4-nitroaniline |
8.85 | 3710033 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
8.85 | 11748828 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
2.95 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.22 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.28 | 16456186 |
MESH:D001321 |
Autistic Disorder |
|
Magnesium |
3.60 | 16846101 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.20 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
ferrous sulfate |
14.46 | 6421970 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
14.46 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
14.46 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.58 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.63 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Cisplatin |
4.67 | 14601052 |
MESH:D001943 |
Breast Neoplasms |
|
Cisplatin |
2.87 | 19526202 18382427 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
2.87 | 17289903 16675129 12948864 17018787 18497071 17261762 19861407 14630087 |
MESH:D001943 |
Breast Neoplasms |
|
Methylnitrosourea |
2.87 | 11306469 14633655 16253758 |
MESH:D001943 |
Breast Neoplasms |
|
Nitric Oxide |
2.87 | 15631943 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.87 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
2.87 | 16873071 16443354 16166294 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.38 | 16813970 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.25 | 16111702 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.57 | 18705752 15673190 16097048 15700767 16192424 16227642 16050911 15721981 10355542 16011737 3786805 16124888 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.63 | 16835633 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
4.95 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
6.32 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cisplatin |
6.32 | 17982673 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
6.32 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
6.32 | 1917145 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
Cisplatin |
2.96 | 12023789 16685392 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Cisplatin |
4.64 | 17066447 6189445 18337622 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
4.64 | 16096774 16051514 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Amiloride |
4.90 | 14644129 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.25 | 18670907 18850075 16120746 |
MESH:D002386 |
Cataract |
|
Methylnitrosourea |
7.34 | 12484553 |
MESH:D002386 |
Cataract |
|
Tretinoin |
7.34 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
6.57 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylnitrosourea |
6.57 | 7505956 2727394 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.38 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
2.99 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Nitric Oxide |
4.30 | 16919318 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
4.95 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.47 | 8697196 16354765 15340226 12621046 15668235 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
5.47 | 9407595 |
MESH:D003092 |
Colitis |
|
Amiloride |
9.30 | 12065299 |
MESH:D003092 |
Colitis |
|
Tretinoin |
9.30 | 17035595 |
MESH:D003111 |
Colonic Polyps |
|
Magnesium |
5.85 | 17823441 |
MESH:D015179 |
Colorectal Neoplasms |
|
Cisplatin |
3.20 | 15273666 |
MESH:D015179 |
Colorectal Neoplasms |
|
Magnesium |
3.20 | 17823441 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.88 | 17141729 14669216 |
MESH:D003327 |
Coronary Disease |
|
Fructose |
4.34 | 18504504 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.38 | 15322242 10048152 20055451 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
2.38 | 9125849 16925845 9211117 17551590 9664655 10589399 14991402 8800419 9142499 9224671 |
MESH:D015140 |
Dementia, Vascular |
|
Nitric Oxide |
5.75 | 17556102 |
MESH:D002658 |
Developmental Disabilities |
|
Magnesium |
4.77 | 16846101 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Fructose |
4.32 | 18603373 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Fructose |
4.48 | 18603373 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.48 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.24 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
3.52 | 19336974 7440962 6884620 2869522 3732212 19085960 15998439 10915739 15027814 4309450 6623471 16177239 10092053 9327722 7120509 15968718 3786805 16227642 11566570 21278145 7179309 17522070 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
3.52 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Cisplatin |
12.99 | 12649298 19839026 15033597 12231392 |
MESH:D004362 |
Drug Toxicity |
|
Gentamicins |
12.99 | 15033597 11033412 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
12.99 | 11462148 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.20 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
11.23 | 18230668 15322242 16714409 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
11.23 | 18230668 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
6.96 | 18566989 11473722 19148513 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
6.96 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.84 | 9294722 10568697 |
MESH:D004938 |
Esophageal Neoplasms |
|
Cisplatin |
2.73 | 15173087 16481741 15464296 16785472 17638652 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
8.32 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
8.32 | 9664655 16938888 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
7.64 | 16239168 12631006 61145 15959796 17595544 12795759 19224547 16045604 |
MESH:D005234 |
Fatty Liver |
|
Fructose |
7.64 | 18395287 18641190 19196556 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.25 | 11858732 |
MESH:D005354 |
Fibrosarcoma |
|
Methylnitrosourea |
5.02 | 11555667 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
19.50 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Fructose |
19.50 | 18504504 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
19.50 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
19.50 | 17994277 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
2.87 | 17312396 |
MESH:D005910 |
Glioma |
|
Methylnitrosourea |
3.48 | 9825942 |
MESH:D018149 |
Glucose Intolerance |
|
Fructose |
5.13 | 19165636 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.38 | 10696789 |
MESH:D006130 |
Growth Disorders |
|
Amiloride |
4.62 | 19703807 |
MESH:D006261 |
Headache |
|
Nitric Oxide |
4.96 | 11284996 11554966 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Cisplatin |
7.45 | 15464296 15102660 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
7.45 | 16096774 |
MESH:D034381 |
Hearing Loss |
|
Cisplatin |
9.70 | 19898482 |
MESH:D034381 |
Hearing Loss |
|
Gentamicins |
9.70 | 18024279 17868369 15968427 19130971 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
4.95 | 16084493 |
MESH:D006319 |
Hearing Loss, Sensorineural |
|
Cisplatin |
4.25 | 15464296 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.17 | 11294989 10048152 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
6.17 | 9664655 14991402 |
MESH:D006333 |
Heart Failure |
|
Dobutamine |
4.32 | 17440445 |
MESH:D006394 |
Hemangiosarcoma |
|
4-nitroaniline |
5.68 | 15200160 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.15 | 11000095 |
MESH:D006486 |
Hemosiderosis |
|
4-nitroaniline |
6.46 | 3710033 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
3.39 | 19110552 19900420 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.69 | 12621046 15340226 16120746 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.82 | 15709030 |
MESH:D006689 |
Hodgkin Disease |
|
Cisplatin |
3.42 | 16200630 16170182 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.54 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.83 | 16354765 18606429 15340226 16959395 8697196 |
MESH:D006930 |
Hyperalgesia |
|
icatibant |
8.16 | 12727271 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
8.16 | 16870215 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.32 | 16899240 |
MESH:D053565 |
Hypercalciuria |
|
Gentamicins |
5.50 | 17652376 |
MESH:D006940 |
Hyperemia |
|
Nitric Oxide |
5.40 | 11156591 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.36 | 16778211 |
MESH:D006946 |
Hyperinsulinism |
|
Fructose |
4.72 | 15752949 18563319 18360027 14757778 19008412 |
MESH:D006949 |
Hyperlipidemias |
|
Fructose |
4.56 | 15752949 |
MESH:D006973 |
Hypertension |
therapeutic |
|
| 14568997 |
MESH:D006973 |
Hypertension |
|
Amiloride |
8.45 | 15174897 18524855 19344079 |
MESH:D006973 |
Hypertension |
|
Fructose |
8.45 | 16843071 19008412 14633139 14568997 14573337 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
8.45 | 18850075 18670907 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
3.88 | 15338365 |
MESH:D006976 |
Hypertension, Pulmonary |
|
Nitric Oxide |
4.27 | 15838368 |
MESH:D015228 |
Hypertriglyceridemia |
|
Fructose |
4.89 | 19799862 19342510 |
MESH:D020514 |
Hypokalemic Periodic Paralysis |
|
Amiloride |
12.42 | 19822448 |
MESH:D020514 |
Hypokalemic Periodic Paralysis |
|
Potassium |
12.42 | 19822448 |
MESH:D007248 |
Infertility, Male |
|
Methylnitrosourea |
3.66 | 7193160 |
MESH:D007249 |
Inflammation |
|
Aluminum |
11.21 | 16052892 |
MESH:D007249 |
Inflammation |
|
Amiloride |
11.21 | 17237260 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
11.21 | 17296493 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
11.21 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
7.34 | 16627594 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Fructose |
7.34 | 19342510 14633139 14757778 18057795 19799862 19586609 17133782 14573337 19008412 18563319 18981581 |
MESH:D007410 |
Intestinal Diseases |
|
Nitric Oxide |
9.42 | 11574821 11713966 10210152 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
9.42 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
9.30 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
9.30 | 15992940 17551590 |
MESH:D007673 |
Kidney Cortex Necrosis |
|
Cisplatin |
12.61 | 15464296 |
MESH:D007673 |
Kidney Cortex Necrosis |
|
Gentamicins |
12.61 | 18842672 |
MESH:D007674 |
Kidney Diseases |
|
Cisplatin |
9.62 | 15190930 12649298 12231392 18289764 19839026 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
9.62 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
Gentamicins |
9.62 | 19349640 18289764 17934191 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
2.81 | 15610895 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Calcium |
18.60 | 16316344 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Cisplatin |
18.60 | 11231351 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Gentamicins |
18.60 | 11231351 |
MESH:D007896 |
Leishmaniasis |
|
Nitric Oxide |
4.48 | 17218153 |
MESH:D016773 |
Leishmaniasis, Cutaneous |
|
Gentamicins |
4.29 | 10219319 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
2.67 | 17143497 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.51 | 19285840 16482212 16932348 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.04 | 17596541 16294345 19850784 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.02 | 16140955 19642359 17368321 19035177 12679006 19075265 16935935 17294898 17301526 16788101 19029980 17361223 17506722 16891316 19225113 17339181 16331271 17712046 15748426 17649720 16766008 17107899 16823087 17217047 9834237 |
MESH:D056929 |
Liddle Syndrome |
|
Amiloride |
5.76 | 19344079 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Methylnitrosourea |
7.97 | 15526292 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
7.97 | 9224671 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
2.69 | 16943688 21278145 11408273 16239168 11903743 17174718 17334410 17157831 16221502 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
4.72 | 12666154 12632514 14748882 12898905 17823541 16192424 18472332 12389079 18277467 17805973 14716496 17922224 17565644 15338365 20821823 18412020 18166357 18251166 18317297 18006644 15876570 14620537 17640975 16638106 12667390 15925388 15959796 12632512 18263696 16248980 12958196 18210741 15996030 17714472 15893842 17761835 15650968 18395914 16097048 18376398 17944888 18472094 16027843 12649538 18420326 15931870 18279442 12445418 17900296 15730626 16033810 17869086 17721639 17708605 17976157 12546737 13678700 17481882 14724832 14512876 18395095 15673190 12445421 15370692 16011737 16136751 18339082 17631135 17766677 17557913 17525996 15818738 10355542 17698563 18481824 18054572 18187930 11481614 15123356 12741479 12586293 15052691 16116963 18429990 18705752 15057751 18156304 14716833 18418968 18205269 15362042 12609069 16015684 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
4.72 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
4.72 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
4.72 | 18397230 16248980 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
2.03 | 15720792 16964402 17285989 16246199 15830285 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
3.96 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
3.51 | 14706259 16899240 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
4.13 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
4.13 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
5.33 | 12014681 15583823 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
5.33 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
Dobutamine |
4.58 | 19353679 |
MESH:D038061 |
Lower Extremity Deformities, Congenital |
|
Methylnitrosourea |
5.26 | 16080182 |
MESH:D008171 |
Lung Diseases |
|
Aluminum |
8.02 | 16052892 |
MESH:D008171 |
Lung Diseases |
|
Dobutamine |
8.02 | 16638327 |
MESH:D055370 |
Lung Injury |
|
Nitric Oxide |
4.52 | 11395602 |
MESH:D008175 |
Lung Neoplasms |
|
Cisplatin |
3.44 | 11798837 17225452 6189445 |
MESH:D008175 |
Lung Neoplasms |
|
Methylnitrosourea |
3.44 | 18062963 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.44 | 19555203 11884234 |
MESH:D008223 |
Lymphoma |
|
Methylnitrosourea |
7.75 | 11418001 16257854 |
MESH:D008223 |
Lymphoma |
|
Nitric Oxide |
7.75 | 16166326 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Methylnitrosourea |
4.58 | 14633661 |
MESH:D008275 |
Magnesium Deficiency |
|
Magnesium |
6.23 | 17823441 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
5.88 | 17203775 11807958 16891317 11408345 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Methylnitrosourea |
5.88 | 15688392 15113128 10767621 16827153 16619500 17020996 15313902 14633655 11751437 12931682 14999141 19196723 10838139 16944150 11807958 16051031 17131329 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.27 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.70 | 17453147 |
MESH:D008545 |
Melanoma |
|
Cisplatin |
3.38 | 12393984 17023156 16809738 17761969 18176117 15577323 12883367 16432458 12374674 18505091 18332650 16248763 11135225 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
3.38 | 16752155 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Cisplatin |
4.56 | 15990972 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.22 | 16940565 |
MESH:D008654 |
Mesothelioma |
|
Cisplatin |
3.16 | 17638057 |
MESH:D024821 |
Metabolic Syndrome X |
|
Fructose |
4.64 | 17098227 19165636 18497449 17261469 16815490 |
MESH:D008661 |
Metabolism, Inborn Errors |
marker/mechanism |
|
| |
MESH:D008708 |
Methemoglobinemia |
|
4-nitroaniline |
5.67 | 3710033 |
MESH:D008881 |
Migraine Disorders |
|
Magnesium |
8.03 | 18803445 |
MESH:D008881 |
Migraine Disorders |
|
Nitric Oxide |
8.03 | 11701602 |
MESH:D020326 |
Migraine without Aura |
|
Nitric Oxide |
4.91 | 11304026 14659530 |
MESH:D020528 |
Multiple Sclerosis, Chronic Progressive |
|
Aluminum |
6.16 | 17086897 |
MESH:D020529 |
Multiple Sclerosis, Relapsing-Remitting |
|
Aluminum |
6.16 | 17086897 |
MESH:D009137 |
Muscular Dystrophy, Animal |
|
Gentamicins |
6.06 | 18694830 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
2.96 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
therapeutic |
|
| 12411458 |
MESH:D017202 |
Myocardial Ischemia |
|
Dobutamine |
8.84 | 12447174 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
8.84 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.12 | 16810080 |
MESH:D009361 |
Neoplasm Invasiveness |
|
Amiloride |
5.10 | 14644129 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
4-aminobenzamidine |
5.26 | 16430655 |
MESH:D009369 |
Neoplasms |
|
Cisplatin |
7.88 | 16773208 |
MESH:D009369 |
Neoplasms |
|
Methylnitrosourea |
7.88 | 15533788 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
7.88 | 16946489 16594593 |
MESH:D009374 |
Neoplasms, Experimental |
|
Methylnitrosourea |
4.27 | 12696579 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.52 | 17289903 |
MESH:D009395 |
Nephritis, Interstitial |
|
Cisplatin |
4.28 | 15464296 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
15.16 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
15.16 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
15.16 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
2.92 | 9142499 |
MESH:D009442 |
Neurilemmoma |
|
Methylnitrosourea |
5.27 | 11555667 |
MESH:D009447 |
Neuroblastoma |
|
Cisplatin |
3.34 | 8761367 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cisplatin |
4.49 | 8761367 |
MESH:D009765 |
Obesity |
|
Fructose |
3.37 | 18585860 17707055 |
MESH:D010024 |
Osteoporosis |
|
Calcium |
3.65 | 17882678 |
MESH:D010051 |
Ovarian Neoplasms |
|
Cisplatin |
7.54 | 17225452 6897625 19769630 15464296 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
7.54 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
7.54 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
2.74 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cisplatin |
8.36 | 19003803 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Methylnitrosourea |
8.36 | 16965848 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
8.36 | 15976015 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.04 | 12520081 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Cisplatin |
4.11 | 15464296 |
MESH:D010997 |
Pleural Neoplasms |
|
Cisplatin |
5.13 | 17638057 |
MESH:D011015 |
Pneumonia, Aspiration |
|
Nitric Oxide |
5.12 | 18573544 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.36 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
2.98 | 11399792 11118676 11222880 11896295 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.69 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
4-aminobenzamidine |
3.10 | 16430655 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
3.10 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Methylnitrosourea |
3.10 | 15682402 12376480 |
MESH:D011507 |
Proteinuria |
|
Gentamicins |
8.89 | 15033597 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
8.89 | 16636307 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.58 | 16723453 |
MESH:D051437 |
Renal Insufficiency |
|
Cisplatin |
9.97 | 15464296 |
MESH:D051437 |
Renal Insufficiency |
|
Gentamicins |
9.97 | 15728788 17132701 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.64 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
Methylnitrosourea |
4.26 | 18172121 18155124 |
MESH:D012173 |
Retinitis |
|
Gentamicins |
6.06 | 18644591 |
MESH:D012175 |
Retinoblastoma |
|
Methylnitrosourea |
5.27 | 11555667 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
3.90 | 16283617 16116481 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Cisplatin |
4.23 | 14601052 |
MESH:D012555 |
Schistosomiasis mansoni |
|
Nitric Oxide |
5.24 | 9673227 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.23 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
5.23 | 16467112 |
MESH:D055752 |
Small Cell Lung Carcinoma |
|
Cisplatin |
5.13 | 15464296 |
MESH:D013158 |
Splenic Diseases |
|
aniline |
6.20 | 15694462 |
MESH:D013274 |
Stomach Neoplasms |
|
Cisplatin |
3.44 | 15958060 17522103 18396642 |
MESH:D013274 |
Stomach Neoplasms |
|
Methylnitrosourea |
3.44 | 16257854 15930296 18593901 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
3.44 | 17261132 |
MESH:D013276 |
Stomach Ulcer |
|
Nitric Oxide |
4.01 | 15138204 |
MESH:D013736 |
Testicular Neoplasms |
|
Cisplatin |
4.43 | 15464296 17225452 |
MESH:D013953 |
Thymus Neoplasms |
|
Methylnitrosourea |
5.02 | 11418001 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.69 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Methylnitrosourea |
6.99 | 7505956 3078959 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
6.99 | 16026305 17045167 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.47 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.60 | 16051514 |
MESH:D016171 |
Torsades de Pointes |
|
Dobutamine |
5.14 | 19353679 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.10 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cisplatin |
2.87 | 15464296 12973940 17225452 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Cisplatin |
8.96 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
8.96 | 16129372 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.40 | 16752155 |
MESH:D014625 |
Vaginal Neoplasms |
|
Cisplatin |
4.40 | 15577323 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.38 | 12125929 |
MESH:D015837 |
Vestibular Diseases |
|
Gentamicins |
5.32 | 18776599 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.85 | 16761959 |
MESH:D014839 |
Vomiting |
|
Cisplatin |
4.51 | 11897121 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.04 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.79 | 16287080 |